What is XRAY stock price today?

Visit our real-time dashboard for the current XRAY stock price and live market data.

Is XRAY stock going up or down today?

XRAY stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy XRAY stock now?

The decision to buy XRAY depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is XRAY a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for XRAY based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is XRAY stock overvalued or undervalued?

Use our DCF valuation calculator to determine if XRAY is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is XRAY's P/E ratio?

P/E ratio data for XRAY will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is XRAY's market cap?

XRAY (Dentsply Sirona Inc) has a market capitalization of $2.01 billion, making it a small-cap stock.

What is XRAY's price to book ratio?

XRAY trades at a price-to-book (P/B) ratio of 1.52, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does XRAY pay dividends?

Yes, XRAY pays dividends with a current yield of 4.59%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is XRAY's dividend yield?

XRAY's dividend yield is 4.59%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is XRAY stock a good long-term investment?

XRAY's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is XRAY's revenue growth rate?

Revenue growth data for XRAY is available on our dashboard with detailed financial statement analysis.

Profitability metrics for XRAY are available on our dashboard with complete income statement analysis.

What are the risks of investing in XRAY?

Key risks for XRAY include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does XRAY compare to its competitors?

Compare XRAY to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize XRAY's performance and positioning.

What is XRAY's stock price target for 2026?

Visit our prediction page for AI-powered price targets for XRAY with bull, base, and bear case scenarios.

What do analysts say about XRAY?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for XRAY. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is XRAY's next earnings report?

XRAY reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

XRAY - Dentsply Sirona Inc

NYSE * Healthcare * Medical Instruments & Supplies

$0.00

+$0.00 (+0.00%)

About Dentsply Sirona Inc

Dentsply Sirona Inc (XRAY) common stock

Price Chart

Loading chart...

XRAY Key Statistics

Market Cap

$2.01B

P/B Ratio

1.52

Dividend Yield

4.59%

How XRAY Compares to Peers

XRAY is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
XRAY(This stock)	$2.01B	N/A	0%	0.0%	-
UNHUnitedHealth Group	$362.83B	30.1	0%	0.0%	vs UNH
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 14, 2026 at 9:02 AM EDT

Ready to invest in XRAY?

Commission-free trading available. Affiliate links.

XRAY Lician Score

10% confidence

4.0/10

Neutral

XRAY has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates XRAYacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

XRAY Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for XRAY

Dashboard

Enter a ticker to analyze